Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Vela Ramirez JE"'
Autor:
Moure CJ; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Vara B; Department of Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey., Cheng MM; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Sondey C; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Muise E; Department of Data and Genome Sciences, Merck & Co., Inc., Rahway, New Jersey., Park E; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Vela Ramirez JE; Department of Discovery Pharmaceutical Sciences, Merck & Co., Inc., Rahway, New Jersey., Su D; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., D'Souza S; Department of Discovery Oncology, Merck & Co., Inc., Rahway, New Jersey., Yan Q; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Yeung CS; Department of Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey., Zhang M; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Mansueto MS; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Linn D; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Buchanan M; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Foti R; Department of PPDM, Merck & Co., Inc., Rahway, New Jersey., DiMauro E; Department of Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey., Long B; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey., Simov V; Department of Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey., Barry ER; Department of Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Aug 01; Vol. 23 (8), pp. 1095-1108.
Autor:
Adams, Michael J. Wannemuehler, Kathleen A. Ross, Marian L. Kohut, Kevin L. Legge, Susan Carpenter, Mallapragadal Sk, Vela Ramirez Je, Lucas Huntimer, Tatiana K. Bronich, Balaji Narasimhan, Webby R
Publikováno v:
Journal of Biomedical Nanotechnology. 10:2261-2294
The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on t
Autor:
Zeng, Yang1 (AUTHOR), Li, Tiantian1 (AUTHOR), Chen, Xueyang1 (AUTHOR), Fang, Xiaowei2 (AUTHOR), Fang, Chun1 (AUTHOR), Liang, Xiongyan1 (AUTHOR), Liu, Jing1 (AUTHOR) 519053@yangtzeu.edu.cn, Yang, Yuying1 (AUTHOR) yangyycn@yangtzeu.edu.cn
Publikováno v:
BMC Veterinary Research. 9/7/2024, Vol. 20 Issue 1, p1-15. 15p.
Autor:
Tian, Kexin1,2 (AUTHOR), Jing, Dehong1,2 (AUTHOR), Lan, Junzhe1,2 (AUTHOR), Lv, Mingming3 (AUTHOR), Wang, Tingting1,2 (AUTHOR) wangtt@nju.edu.cn
Publikováno v:
Immunity, Inflammation & Disease. Jul2024, Vol. 12 Issue 7, p1-22. 22p.
Autor:
Caldorera-Moore M; a Department of Biomedical Engineering , Louisiana Tech University , Ruston , LA , USA., Vela Ramirez JE; b McKetta Department of Chemical Engineering , The University of Texas at Austin , Austin , TX , USA.; c Department of Biomedical Engineering , The University of Texas at Austin , Austin , TX , USA.; d Institute for Biomaterials, Drug Delivery, and Regenerative Medicine , The University of Texas at Austin , Austin , TX , USA., Peppas NA; b McKetta Department of Chemical Engineering , The University of Texas at Austin , Austin , TX , USA.; c Department of Biomedical Engineering , The University of Texas at Austin , Austin , TX , USA.; d Institute for Biomaterials, Drug Delivery, and Regenerative Medicine , The University of Texas at Austin , Austin , TX , USA.; e Department of Surgery and Perioperative Care , Dell Medical School, The University of Texas at Austin , Austin , TX , USA.; f Department of Pediatrics , Dell Medical School, The University of Texas at Austin , Austin , TX , USA.; g Division of Molecular Pharmaceutics and Drug Delivery , College of Pharmacy, The University of Texas at Austin , Austin , TX , USA.
Publikováno v:
Journal of drug targeting [J Drug Target] 2019 Jun - Jul; Vol. 27 (5-6), pp. 582-589. Date of Electronic Publication: 2019 Mar 01.
Autor:
Liechty WB; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA., Scheuerle RL; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA., Vela Ramirez JE; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: jvela87@utexas.edu., Peppas NA; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX 78712, USA; Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: peppas@che.utexas.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2019 May 01; Vol. 562, pp. 249-257. Date of Electronic Publication: 2019 Mar 08.
Autor:
Oldenkamp HF; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA.; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA., Vela Ramirez JE; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA.; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA., Peppas NA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA.; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.; Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.
Publikováno v:
Regenerative biomaterials [Regen Biomater] 2019 Feb; Vol. 6 (1), pp. 1-12. Date of Electronic Publication: 2018 Nov 14.
Autor:
Vela Ramirez JE; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA., Sharpe LA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA., Peppas NA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA; Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX, USA; Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA. Electronic address: peppas@che.utexas.edu.
Publikováno v:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2019 Jan 15; Vol. 139, pp. 158. Date of Electronic Publication: 2018 Sep 03.
Autor:
Orive G; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain; University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain; Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore. Electronic address: gorka.orive@ehu.eus., Santos-Vizcaino E; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain., Pedraz JL; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain., Hernandez RM; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain., Vela Ramirez JE; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA., Dolatshahi-Pirouz A; Department of Micro- and Nanotechnology, Center for Nanomedicine and Theranostics, Technical University of Denmark, Kgs. Lyngby, 2800, Denmark., Khademhosseini A; Department of Bioengineering, Department of Chemical and Biomolecular Engineering, Henry Samueli School of Engineering and Applied Sciences, University of California-Los Angeles, Los Angeles, CA, USA; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, Los Angeles, CA, USA; California NanoSystems Institute (CNSI), University of California-Los Angeles, Los Angeles, CA, USA; Department of Radiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Peppas NA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA; Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Emerich DF; Gloriana Therapeutics, Inc, 225 Chapman St., Providence, RI, USA. Electronic address: DFE@GlorianaTx.com.
Publikováno v:
Progress in retinal and eye research [Prog Retin Eye Res] 2019 Jan; Vol. 68, pp. 67-82. Date of Electronic Publication: 2018 Oct 18.
Autor:
Liechty WB; McKetta Dept. of Chemical Engineering The University of Texas at Austin Austin TX 78712., Scheuerle RL; McKetta Dept. of Chemical Engineering The University of Texas at Austin Austin TX 78712., Vela Ramirez JE; McKetta Dept. of Chemical Engineering The University of Texas at Austin Austin TX 78712.; Dept. of Biomedical Engineering The University of Texas at Austin Austin TX 78712.; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine The University of Texas at Austin Austin TX 78712., Peppas NA; McKetta Dept. of Chemical Engineering The University of Texas at Austin Austin TX 78712.; Dept. of Biomedical Engineering The University of Texas at Austin Austin TX 78712.; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine The University of Texas at Austin Austin TX 78712.; Depts. of Surgery and Perioperative Care Dell Medical School, The University of Texas at Austin Austin TX 78712.; Division of Molecular Pharmaceutics and Drug Delivery College of Pharmacy, The University of Texas at Austin Austin TX 78712.
Publikováno v:
Bioengineering & translational medicine [Bioeng Transl Med] 2018 Nov 22; Vol. 4 (1), pp. 17-29. Date of Electronic Publication: 2018 Nov 22 (Print Publication: 2019).